TTrialPathMatch Me to Trials
← Back to trials
RecruitingArrhythmogenic Right Ventricular CardiomyopathyCardiomyopathiesHeart Diseases

Mayo AVC Registry and Biobank

Eligible age

All ages

Accepts

All genders

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Arrhythmogenic ventricular cardiomyopathy (AVC) is a genetic condition which affects the heart and can lead to heart failure and rhythm problems, of which, sudden cardiac arrest or death is the most tragic and dangerous. Diagnosis and screening of blood-relatives is very difficult as the disease process can be subtle, but sufficient enough, so that the first event is sudden death. The Mayo Clinic AVC Registry is a collaboration between Mayo Clinic, Rochester, USA and Papworth Hospital, Cambridge University Hospitals, Cambridge, UK. The investigators aim to enroll patients with a history of AVC or sudden cardiac death which may be due to AVC, from the US and UK. Family members who are blood-relatives will also be invited, including those who do not have the condition. Data collected include symptoms, ECG, echocardiographic, MRI, Holter, loop recorder, biopsies, exercise stress testing, blood, buccal and saliva samples. Objectives of the study: 1. Discover new genes or altered genes (variants) which cause AVC 2. Identify biomarkers which predict (2a) disease onset, (2b) disease progression, (2c) and the likelihood of arrhythmia (ventricular, supra-ventricular and atrial fibrillation) 3. Correlate genotype with phenotype in confirmed cases of AVC followed longitudinally using clinical, electrocardiographic and imaging data. 4. Characterize desmosomal changes in buccal mucosal cells with genotype and validate with gold-standard endomyocardial biopsies

Sponsor: Mayo Clinic

You may qualify if…

  • ✓ Patients with a diagnosis of a non-MI SCA who survived
  • ✓ Patients with a non-MI SCD
  • ✓ Patient with a SCA associated with seizures, epilepsy, syncope, drowning and near-drowning, where a cardiomyopathy is suspected
  • ✓ Family member of a patient diagnosed with primary cardiomyopathy (including HCM, idiopathic DCM, AVC)

You may not qualify if…

  • ✕ Patients with a clear, unambiguous known cause of SCA or SCD such as myocardial infarction or heart failure secondary to ischemic heart disease
  • ✕ Significant coronary artery disease (Epicardial coronary artery stenosis \>50%) which can explain degree of LV dysfunction
  • ✕ Those unwilling to provide written consent or assent

Where it's recruiting

Minnesota

Rochester

Source: ClinicalTrials.gov · NCT03049254 · last updated 2026-04-27

Mayo AVC Registry and Biobank · TrialPath